| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $329.5M | +12.5% |
| Cost of Revenue | $79.4M | +4.0% |
| Gross Profit | $250.1M | +15.4% |
| R&D Expense | $8.5M | -4.0% |
| SG&A Expense | $88.7M | +24.7% |
| Operating Income | $29.3M | +32.0% |
| Pre-tax Income | $31.3M | +33.4% |
| Income Tax | $12.3M | +87.7% |
| Net Income | $19.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $83.4M | -11.6% |
| Accounts Receivable | $43.9M | -2.4% |
| Inventory | $14.0M | -24.9% |
| Current Assets | $165.2M | -7.0% |
| Total Assets | $273.9M | -8.0% |
| Current Liabilities | $41.0M | +0.6% |
| Long-term Debt | $0 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $42.8M | +5.3% |
| Capital Expenditures | $2.4M | -0.5% |
| Investing Cash Flow | -$2.5M | -1.5% |
| Financing Cash Flow | -$51.2M | -961.3% |
| Free Cash Flow | $40.4M | +5.7% |
| +12.5% |
| EPS (Basic) | $0.83 | +16.9% |
| EPS (Diluted) | $0.82 | +17.1% |
| Total Liabilities |
| $55.0M |
| -32.3% |
| Stockholders' Equity | $218.9M | +1.1% |